Rheumatology Department, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Chest Department, Kasr Al Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
Infection. 2024 Aug;52(4):1337-1345. doi: 10.1007/s15010-024-02187-z. Epub 2024 Feb 21.
This aimed to identify the factors associated with severe/critical coronavirus disease 2019 (COVID-19) infection in rheumatoid arthritis (RA) patients.
Two-hundred RA patients diagnosed according to the American College of Rheumatology/ European League Against Rheumatism (ACR/EULAR) classification criteria with proven COVID-19 infection were recruited and categorized according to the world health organization (WHO) COVID-19 severity grading into 2 groups: patients with mild/moderate COVID-19 (n = 164) and patients with severe/critical COVID-19 (n = 36). Comparison between both groups was done to identify the risk factors associated with severe/critical infection. Incidence of RA disease activity flare defined as increase in clinical disease activity index (CDAI) more than 10 points following infection was calculated.
Multivariate analysis identified history of previous serious infection, age > 60 years, and diabetes as factors positively associated, whereas COVID-19 vaccination was negatively associated with severe/critical infection. Following COVID-19 infection, the number of patients with severe/critical COVID-19 who had high RA disease activity and the incidence of flares was significantly higher in comparison to patients with mild/moderate COVID-19 (P < 0.001 and 0.003; respectively).
Age > 60 years, diabetes, and history of previous serious infections are risk factors for severe/critical COVID-19, while vaccination has a protective role in RA patients. Infection particularly when severe is associated with risk of disease flare.
本研究旨在确定与类风湿关节炎(RA)患者严重/危重新冠病毒病 2019(COVID-19)感染相关的因素。
共招募了 200 名符合美国风湿病学会/欧洲抗风湿病联盟(ACR/EULAR)分类标准诊断的 RA 患者,且经证实患有 COVID-19 感染,并根据世界卫生组织(WHO)COVID-19 严重程度分级标准分为 2 组:轻度/中度 COVID-19 患者(n=164)和严重/危重新冠病毒病患者(n=36)。对两组患者进行比较,以确定与严重/危重症感染相关的危险因素。计算感染后临床疾病活动指数(CDAI)增加超过 10 分的 RA 疾病活动发作的发生率。
多变量分析确定了既往严重感染史、年龄>60 岁和糖尿病是正相关的因素,而 COVID-19 疫苗接种与严重/危重症感染呈负相关。与轻度/中度 COVID-19 患者相比,感染 COVID-19 后,严重/危重症 COVID-19 患者中出现高 RA 疾病活动度和发作的患者数量显著更高(P<0.001 和 0.003)。
年龄>60 岁、糖尿病和既往严重感染史是严重/危重新冠病毒病的危险因素,而接种疫苗对 RA 患者具有保护作用。感染,尤其是重症感染,与疾病发作的风险相关。